Methods and compositions for inducing an immune response to EGFRvIII
US9200057B2 · kind B2 · utility
3Cited by
9References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 17, 2011 |
| Grant date | Dec 1, 2015 |
| Priority date | — |
| Expiry date | Nov 17, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/523
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of inducing a T-cell response against a EGFRvIII in a subject. These method comprise administering to a subject a composition which expresses at least one immunogenic polypeptide, the amino acid sequence of which comprise a plurality of EGFRvIII polypeptide sequences, the sequence of which each comprise EEKKGNYV (SEQ ID NO: 3), and/or administering the polypeptide itself.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.